El presidente electo de la SEHH reivindica la medicina de precisión…
El presidente electo de la Sociedad Española de Hematología y Hemoterapia (SEHH) y presidente del Grupo…
Related Articles
Effect of Sacubitril/Valsartan or Enalapril on Left Ventricular Function in Patients With Hematologic Malignancies Treated With Bone Marrow Transplantation: A Randomized Controlled Trial
AbstractBackgroundIn patients with bone marrow transplantation (BMT) for hematologic malignancies, evidence for prevention of cancer therapy-related cardiac dysfunction (CTRCD) remains limited.Obje…
Membership and Communities – ESC Council of Cardio-Oncology
Your access to the latest cardiovascular news, science, tools and resources.
Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
The field of cardio-oncology was born from the necessity for recognition and management of cardiovascular diseases among patients with cancer. This need for this specialty…
Use of new and emerging cancer drugs: what the cardiologist needs to know
Abstract. The last decade has witnessed a paradigm shift in cancer therapy, from non-specific cytotoxic chemotherapies to agents targeting specific molecul
About ESC Cardio-Oncology Annual Conference
Annual Conference of the ESC Council of Cardio-Oncology.
The current landscape of frontline large B-cell lymphoma trials
Since the addition of rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), major advances in first-line therapy of large B-cell
About ESC Cardio-Oncology Annual Conference
Annual Conference of the ESC Council of Cardio-Oncology.
Spatial transcriptomics of progression gene signature and tumor microenvironment leading to progression in mycosis fungoides
Key PointsA progression signature was found that commonly increased in expression during the progression from patch to plaque and from plaque to tumor.M2 m
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi
Key PointsAchievement of CMR after 4 cycles of first-line ICT is associated with improved outcomes in FL patients.The prognostic role of early metabolic re
Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis
Key PointsAn NMA of BTKis found zanubrutinib to be the most efficacious treatment for patients with high-risk R/R CLL.Zanubrutinib demonstrated reduced ris